Literature DB >> 1391489

Intravascular reduction of methemoglobin in plasma of the rat in vivo.

P J den Boer1, W K Bleeker, G Rigter, J Agterberg, P Stekkinger, L M Kannegieter, I M de Nijs, J C Bakker.   

Abstract

The formation and reduction of extracellular methemoglobin (metHb) in plasma was studied in vivo in conscious rats after isovolemic exchange transfusions with polymerized hemoglobin solutions. After exchange transfusions of 40 and 70% of the blood volume with hemoglobin solutions, containing less than 6% methemoglobin, the methemoglobin level remained below 15%, whereas exchange transfusions of greater than 90% resulted in an increase in the metHb level to about 30% after 24 hours. The reduction of metHb was studied after exchange transfusions with fully oxidized hemoglobin. A gradual decrease in the metHb level to 20% was observed after exchanges of 5 or 40%. A higher exchange transfusion (70%) resulted also in a decrease in the metHb level but only to approximately 40% in 24 hours. In another series of experiments the reduction of metHb was studied in vitro with isolated human erythrocytes. Incubation of the erythrocytes in the presence of oxidized polymerized hemoglobin (3 g%) resulted in a decrease in the percentage of metHb from 91% to 64%. In the presence of 0.2 mM ascorbic acid the metHb level declined to 22%, suggesting a synergistic effect. These results indicate (1) that there is a potent reducing mechanism present in blood that can reduce extracellular oxidized polymerized hemoglobin and (2) that isolated erythrocytes have a large capacity to reduce extracellular metHb, and may also play an important role in the reduction of extracellular metHb in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1391489     DOI: 10.3109/10731199209119695

Source DB:  PubMed          Journal:  Biomater Artif Cells Immobilization Biotechnol        ISSN: 1055-7172


  4 in total

1.  In vivo reduction of cell-free methemoglobin to oxyhemoglobin results in vasoconstriction in canines.

Authors:  Dong Wang; Barbora Piknova; Steven B Solomon; Irene Cortes-Puch; Steven J Kern; Junfeng Sun; Tamir Kanias; Mark T Gladwin; Christine Helms; Daniel B Kim-Shapiro; Alan N Schechter; Charles Natanson
Journal:  Transfusion       Date:  2013-03-14       Impact factor: 3.157

2.  Reduction of NO-induced methemoglobinemia requires extremely high doses of ascorbic acid in vitro.

Authors:  J Dötsch; S Demirakça; A Cryer; J Hänze; P G Kühl; W Rascher
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

3.  Antioxidant effect of different vitamins on methemoglobin production: An in vitro study.

Authors:  Nahid Atyabi; Seyedeh Parastoo Yasini; Seyedeh Missagh Jalali; Hamid Shaygan
Journal:  Vet Res Forum       Date:  2012       Impact factor: 1.054

4.  Cost of Beauty; Prilocaine Induced Methemoglobinemia.

Authors:  Elif Kilicli; Gokhan Aksel; Betul Akbuga Ozel; Cemil Kavalci; Dilek Suveren Artuk
Journal:  Turk J Emerg Med       Date:  2016-03-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.